Skip to main content
Clinical Trials/DRKS00019082
DRKS00019082
Recruiting
Not Applicable

Analysis of clinical, genetical, immunological and microbial factors in IBD patients to identify new prognostic and predictive factors to further optimize and personalize IBD management - The SIGMOID Study

Medizinische Hochschule Hannover0 sites200 target enrollmentMay 25, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
K50.1Ulcerative colitis
Sponsor
Medizinische Hochschule Hannover
Enrollment
200
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 25, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Medizinische Hochschule Hannover

Eligibility Criteria

Inclusion Criteria

  • IBD diagnosis \> 3 months
  • On ward/ out\-patient treatment at the
  • Hannover medical school
  • Signed informed consent
  • Upcoming colonoscopic evaluation
  • Caucasian ethnicity

Exclusion Criteria

  • Active Malignancies
  • Hereditary Immunodeficiencies
  • Any disorders which do not allow the
  • individual to assess the nature, scope and potential consequences of the clinical trial
  • Other ethnicities then Caucasian
  • Antibiotic use within the past 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials